| Graciela Valverde, SLP | |
|
2203 Babcock Rd, San Antonio, TX 78229-4412 | |
| (210) 614-3911 | |
| (210) 616-0443 |
| Full Name | Graciela Valverde |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2203 Babcock Rd, San Antonio, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003997842 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 19929 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Graciela Valverde, SLP 2203 Babcock Rd, San Antonio, TX 78229-4412 Ph: (210) 614-3911 | Graciela Valverde, SLP 2203 Babcock Rd, San Antonio, TX 78229-4412 Ph: (210) 614-3911 |
News Archive
Physicians in the Neonatal Intensive Care Unit in the Maxine Dunitz Children's Health Center launched a pilot study in which mothers' breast milk is analyzed to determine whether premature infants are receiving the correct amounts of nutrients they need to thrive.
The probability of blindness due to the serious eye disease glaucoma has decreased by nearly half since 1980, according to a study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. The researchers speculate that advances in diagnosis and therapy are likely causes for the decrease, but caution that a significant proportion of patients still progress to blindness.
Researchers at Jefferson's Maternal Addiction Treatment Education & Research (MATER) program found significant improvement in the quality of parenting among mothers who participated in a trauma-informed, mindfulness-based parenting intervention while also in medication-assisted treatment for opioid use disorder.
The U.S. Food and Drug Administration (FDA) has approved Merck & Co.'s Juvisync diabetes drug, a combination pill for type 2 diabetes. Juvisync combines two Merck drugs already on the market, 1) glucose-lowering Januvia (Sitagliptin) medication and 2) cholesterol-lowering Zocor (Simvastatin).
One of the few large studies to report long-term outcomes in cardiac patients treated in childhood with extracorporeal membrane oxygenation has found overall favorable outcomes among survivors, as reported by families. ECMO provides short-term breathing and heart support for critically ill children while doctors treat the underlying illness.
› Verified 9 days ago
Miss Julia Shad, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7390 Barlite Blvd Ste315, San Antonio, TX 78224 Phone: 210-787-1583 | |
Anne Wright, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4775 Hamilton Wolfe Rd Ste 1, San Antonio, TX 78229 Phone: 210-616-0283 Fax: 210-616-0071 | |
Robin Coop, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2203 Babcock Rd, San Antonio, TX 78229 Phone: 210-614-3911 Fax: 210-616-0443 | |
Mrs. Shara Renee De Los Santos, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1020 Central Pkwy S, San Antonio, TX 78232 Phone: 121-079-8227 | |
Karen Coulter, CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2203 Babcock Rd, San Antonio, TX 78229 Phone: 210-614-3911 Fax: 210-616-0443 | |
Jesus Huerta Jr., Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 98 Briggs St, Suite 990, San Antonio, TX 78224 Phone: 210-226-9536 Fax: 817-789-6849 | |
Clarissa Fernandez, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10609 Ih 10 W, Suite 201, San Antonio, TX 78230 Phone: 210-344-5437 Fax: 210-340-1259 |